Welcome to Multibagg AI
Log in to access personalized features
Home
Dashboard
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Shelter Pharma Ltd (SHELTER) is currently trading at 34.60 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Shelter Pharma Limited, originally Shelter Pharmacy, is a manufacturer of ayurvedic and herbal products with a strong presence in the Human and Veterinary Pharma sectors. Originally a local business in Himmatnagar, it expanded throughout Gujarat, leveraging in-house R&D for product portfolio enhancement. Recently, Shelter Pharma underwent organizational restructuring, invested in manufacturing capacity, and sourced raw materials directly from nearby farmers. Its recent IPO raised approximately Rs 16.02 Crore, indicating robust investor confidence for expansion plans. The company is continuing its expansion strategically, leveraging a strong product portfolio and focused marketing to capture opportunities in both human and veterinary markets.
Over the past 52 weeks, Shelter Pharma Ltd has traded between a low of ₹30.21 and a high of ₹50.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Shelter Pharma Ltd has a market capitalization of approximately 56.13. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Shelter Pharma Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 5.53 and operates in the Pharmaceuticals sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 56.13 Cr, Shelter Pharma Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Shelter Pharma Ltd operates in the Pharmaceuticals sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Shelter Pharma Ltd is 5.53. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Bearish
5
Neutral
5
Bullish
4
Bearish
28
Neutral
5
Bullish
13
Bearish
23
Neutral
0
Bullish
9
Discovery themes featuring this stock
Shelter Pharma Limited, originally Shelter Pharmacy, is a manufacturer of ayurvedic and herbal products with a strong presence in the Human and Veterinary Pharma sectors.
Originally a local business in Himmatnagar, it expanded throughout Gujarat, leveraging in-house R&D for product portfolio enhancement.
Recently, Shelter Pharma underwent organizational restructuring, invested in manufacturing capacity, and sourced raw materials directly from nearby farmers.
Its recent IPO raised approximately Rs 16.02 Crore, indicating robust investor confidence for expansion plans.
The company is continuing its expansion strategically, leveraging a strong product portfolio and focused marketing to capture opportunities in both human and veterinary markets.
Pharmaceuticals
Pharmaceuticals - Indian - Bulk Drugs
56 Cr
High Risk
5.5
56.9
0.1
0.9
50.00
30.21
Sales CAGR
Profit CAGR
ROE
ROCE
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
| Symbol | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
49.99 | 73 Cr | 200.53 | 2.72 | 0.00 | 2.42 | 3.29 | 2.78 | |
78.50 | 70 Cr | 12.79 | 1.81 | 0.00 | 0.00 | 0.00 | 4.00 | |
227.75 | 67 Cr | -42.02 | 0.94 | 0.46 | 2.22 | 4.92 | -1.28 | |
83.00 | 62 Cr | 16.90 | 1.44 | 0.00 | 12.65 | 11.11 | 2.27 | |
34.60 | 56 Cr | 5.53 | 0.94 | 0.00 | 13.52 | 17.90 | 12.26 | |
34.65 | 48 Cr | 216.56 | 2.10 | 0.00 | 1.08 | 3.59 | 1.00 | |
43.40 | 35 Cr | 17.79 | 1.94 | 0.00 | 10.56 | 10.48 | 2.23 |
